Table 1 Baseline characteristics and demographics of patients included in the study
Mean ± SD (except where stated otherwise) | Folic acid 10 mg per week (FA10) | Folic acid 30 mg per week (FA30) | P value |
|---|---|---|---|
N = 51 | N = 49 | ||
Age, years | 44.8 ± 10.0 | 43.8 ± 11.9 | 0.7 |
Female, number (%) | 44 (86) | 41 (84) | 0.8 |
Duration of disease, years | 4.4 ± 4.1 | 5.2 ± 5.1 | 0.4 |
Disease activity score (DAS28(3)) | 5.8 ± 0.9 | 5.7 ± 0.9 | 0.9 |
Tender joint count, 0–28 | 11.0 ± 4.8 | 11.2 ± 5.2 | 0.8 |
Swollen joint count, 0–28 | 5.1 ± 3.3 | 5.6 ± 3.6 | 0.5 |
HAQ, 0–3 | 1.1 ± 0.5 | 1.1 ± 0.5 | 0.7 |
Hemoglobin, g/dl | 10.8 ± 1.7 | 10.9 ± 2.0 | 0.7 |
Serum albumin, g/dl | 4.0 ± 0.5 | 3.9 ± 0.6 | 0.7 |
ESR, mm, first hour | 65.4 ± 33.2 | 59.5 ± 30.0 | 0.3 |
Rheumatoid factor-positive, number (%) | 42 (84) | 35 (71) | 0.2 |
ACPA-positive, number positive/number tested (%) | 45/48 (94) | 39/43 (91) | 0.6 |